RadNet (NASDAQ:RDNT) and Joint (NASDAQ:JYNT) Head-To-Head Analysis

Joint (NASDAQ:JYNT) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Insider and Institutional Ownership

76.9% of Joint shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 30.2% of Joint shares are owned by company insiders. Comparatively, 5.1% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Joint and RadNet”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Joint	$54.90 million	1.85	$2.91 million	$0.27	26.67
RadNet	$2.04 billion	2.71	-$18.65 million	($0.27)	-260.52

Joint has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Joint and RadNet’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Joint	6.49%	12.02%	3.47%
RadNet	-0.93%	2.61%	0.91%

Volatility & Risk

Joint has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Joint and RadNet, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Joint	1	2	0	0	1.67
RadNet	1	0	5	3	3.11

RadNet has a consensus target price of $90.00, suggesting a potential upside of 27.95%. Given RadNet’s stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Joint.

Summary

RadNet beats Joint on 8 of the 15 factors compared between the two stocks.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

About RadNet

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.